药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methylphenobarbital
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Docetaxel.
Methylphenobarbital
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Docetaxel.
Methylphenobarbital
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Docetaxel.
Methylphenobarbital
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Docetaxel.
Methylphenobarbital
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Docetaxel.
Methylphenobarbital
Desirudin
The risk or severity of bleeding can be increased when Desirudin is combined with Docetaxel.
Methylphenobarbital
Parnaparin
The risk or severity of bleeding can be increased when Parnaparin is combined with Docetaxel.
Methylphenobarbital
Bemiparin
The risk or severity of bleeding can be increased when Bemiparin is combined with Docetaxel.
Methylphenobarbital
Dextran
The risk or severity of bleeding can be increased when Dextran is combined with Docetaxel.
Methylphenobarbital
Sodium citrate
The risk or severity of bleeding can be increased when Sodium citrate is combined with Docetaxel.
Methylphenobarbital
Potassium citrate
The risk or severity of bleeding can be increased when Potassium citrate is combined with Docetaxel.
Methylphenobarbital
Ditazole
The risk or severity of bleeding can be increased when Ditazole is combined with Docetaxel.
Methylphenobarbital
Nadroparin
The risk or severity of bleeding can be increased when Nadroparin is combined with Docetaxel.
Methylphenobarbital
Ferulic acid
The risk or severity of bleeding can be increased when Ferulic acid is combined with Docetaxel.
Methylphenobarbital
Tinzaparin
The risk or severity of bleeding can be increased when Tinzaparin is combined with Docetaxel.
Methylphenobarbital
Dalteparin
The risk or severity of bleeding can be increased when Dalteparin is combined with Docetaxel.
Methylphenobarbital
Danaparoid
The risk or severity of bleeding can be increased when Danaparoid is combined with Docetaxel.
Methylphenobarbital
Amediplase
The risk or severity of bleeding can be increased when Amediplase is combined with Docetaxel.
Methylphenobarbital
Otamixaban
The risk or severity of bleeding can be increased when Otamixaban is combined with Docetaxel.
Methylphenobarbital
Astaxanthin
The risk or severity of bleeding can be increased when Astaxanthin is combined with Docetaxel.